SCHEMBL8504391

SCHEMBL8504391

CCCCc1c(F)c(C(=O)OC(C)(C)C)c(N2CCC2N)c2c1C(C(=O)NCC(F)(F)F)c1cc(F)ccc1-2

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NR3C2 P08235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8669577 0.96 NR3C2 (0.31) NR3C2
SCHEMBL8484144 0.90 KCNA3 (0.32) NR3C2
SCHEMBL8482325 0.83 NR3C2 (0.32) NR3C2
SCHEMBL8663542 0.72 POLB (0.34) —
SCHEMBL8479120 0.72 POLB (0.34) —
SCHEMBL8665948 0.71 PGR (0.31) —
SCHEMBL8486153 0.71 — —
SCHEMBL8679135 0.70 L3MBTL1 (0.36) —
SCHEMBL8480060 0.69 CCR3 (0.40) —
SCHEMBL8666046 0.68 L3MBTL1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5885983-A ANTICHOLESTEROL AGENTS, ANTILIPOLYTIC AGENTS, ANTILIPEMIC AGENTS FOR TREATING HYPERLIPEMIA, ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-23 — — US disclosed
Send feedback